Frontiers in Pharmacology

Original Research

Accepted on 20 Oct 2025

Therapeutic Efficacy of Deslanoside in Oleic Acid-Induced Acute Lung Injury in Rabbits: Implications for Clinical Drug Use and Pharmacological Strategies

Rong Hu
Yi Zheng
Ning Li
Yong Pan
Xiaozhen Zhou
Lu Liu
Dizheng Liao
Yafei Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1683838

Original Research

Accepted on 20 Oct 2025

Prediction and quality evaluation of quality markers of Gentiana scabra Bunge. in treatment of liver injury

佳怡刘
Xuelin Yu
Jiayi Luo
Dan Wang
Haibo Yin

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1679981

Review

Accepted on 20 Oct 2025

Mechanistic insights into the antitumor effects of Astragaloside IV and Astragalus polysaccharide in digestive system cancers

Qingxin Shang
Zhenhua Cui

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1691011

Original Research

Accepted on 20 Oct 2025

Trehalose Alleviates Nephropathy in Focal Segmental Glomerulosclerosis via the Upregulation of WT-1/EZH2 Pathway

Maha Al-Asmakh
Marwa Al Riyami
Miytha Al Marbuii
Shadia Al Sinawi
Suaad Said AL Badi
Faisal AL Ismaili
Amira Alkharusi
Razan Al Zadjali
Zaina Alharthi
Sara Al Mashrafi

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1706617

Original Research

Accepted on 20 Oct 2025

EAR-20 peptide, a novel NMDA receptor positive allosteric modulator

Roberto García-Díaz
Aida Castellanos
Federico Miguez-Cabello
Javier Picañol
Anna Priscil·la Pérez-González
Esther Gratacòs-Batlle
Nohora Vega
Xavier Altafaj
Edwin A Reyes-Guzmán
Edgar A Reyes-Montaño

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1639698

Original Research

Accepted on 20 Oct 2025

Selective anti-cancer effects of cannabidiol and Δ9-Tetrahydrocannabinol via PI3K/AKT/mTOR inhibition and PTEN restoration in ovarian cancer cells

Siyao Tong
Watcharin Loilome
Nisana Namwat
Poramate Klanrit
Arporn Wangwiwatsin
Zar Zar Win
Preeya Koyabuth
Bandit Chumworathayi

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1693129

Systematic Review

Accepted on 20 Oct 2025

Astragalus Polysaccharides Combined with Radiochemotherapy for Cervical Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Studies

Tao Sun
Ruping Zhao
Yaling Zhang
Dongdong Li
Xishen Shan
Xiaoyu Tang
Yuling Zheng

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1699902

Case Report

Accepted on 20 Oct 2025

Case Report: Near-Fatal Adverse Effects of Dopamine Agonist for the Treatment of Restless Legs Syndrome

Jeremiah B Joyce
Liliana Patarroyo Rodriguez
Christopher L Sola

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1697935

Original Research

Accepted on 20 Oct 2025

Regulation of inflammatory pathways by cannabigerol in the collagen induced arthritis model in rats

Monika Šteigerová
Michaela Sklenárová
Mykhaylo Bazyuk
Luděk Záveský
Petr Jelínek
Mahak Arora
Daniel Stránský
Tomáš Kučera
Bruno Sepodes
Miroslav Šoóš

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1705962

Perspective

Accepted on 20 Oct 2025

Advances in Clinical Application on Nursing Intervention for Ribavirin-Associated Adverse Events

Li-Li Jiang
Qing Wang
Jia-Xin Zhang
Jing-Hui Fan
Jing Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1596007

Clinical Trial

Accepted on 20 Oct 2025

Atorvastatin as an Immunomodulatory Adjunct in Ulcerative Colitis, Beyond Lipid Lowering to Inflammation Control: A Randomized Controlled Pilot Study

Mohannad Omar
Furqan M. Abdulelah
Nada A. Saleh
Hayam Ali AlRasheed
Tarek I. Ahmed
Azza Mansy
Manal Hamouda
Eslam Habba
Noura M. Elshorbagi
Ahmed G. Abdelhameed

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1690513

Original Research

Accepted on 20 Oct 2025

Development of a Venous Thromboembolism Risk Prediction Model for Patients with Primary Membranous Nephropathy Based on Machine LearningDevelopment of a Personalized VTE Risk Prediction Model for Patients with Primary Membranous Nephropathy Based on Machine Learning

Li Lian
Liuyun Wu
yin wang
Xingyue Zheng
Lizhu Han
Qinan Yin
Xingwei Wu
Bian Yuan

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1683708

Mini Review

Accepted on 20 Oct 2025

PLGA-based nanoparticles in colorectal cancer immunotherapy: current concepts and future perspectives

YuHan Wang
Peng Huang
Chun Li
ShengJin Tu
Hua Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1714460

Original Research

Accepted on 20 Oct 2025

Cost-effectiveness of Edaravone Dexborneol Sublingual Tablet Versus Concentrated Solution for Injection for the Treatment of Acute Ischemic Stroke in China

Fan Xie
Yuqiong Lu
Zhuo Yang
Yanlei ZHANG
Yujin Bao
Yun Lu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1661581

Original Research

Accepted on 20 Oct 2025

Effect of Recombinant Human Erythropoietin on Postoperative Anemia in Children and Adolescents Undergoing Osteosarcoma and Potential Influencing Factors: A Single-center Retrospective Study

Lulu Liu
Meili Lin
Yang Wenjun
Difei Yao
Huan Luo
Lingyan Yu
Haibin Dai

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1637441

Review

Accepted on 20 Oct 2025

Bromodomain-containing 4 as a therapeutic target in inflammatory bowel diseases and colorectal cancer

Irene Marafini
Rachele Frascatani
Marco Colella
Elena De Cristofaro
Giovanni Monteleone

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1682223

28,291 Publications

Volume 16 - 2025

Therapeutic Efficacy of Deslanoside in Oleic Acid-Induced Acute Lung Injury in Rabbits: Implications for Clinical Drug Use and Pharmacological Strategies

Prediction and quality evaluation of quality markers of Gentiana scabra Bunge. in treatment of liver injury

Mechanistic insights into the antitumor effects of Astragaloside IV and Astragalus polysaccharide in digestive system cancers

Trehalose Alleviates Nephropathy in Focal Segmental Glomerulosclerosis via the Upregulation of WT-1/EZH2 Pathway

EAR-20 peptide, a novel NMDA receptor positive allosteric modulator

Selective anti-cancer effects of cannabidiol and Δ9-Tetrahydrocannabinol via PI3K/AKT/mTOR inhibition and PTEN restoration in ovarian cancer cells

Astragalus Polysaccharides Combined with Radiochemotherapy for Cervical Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Studies

Case Report: Near-Fatal Adverse Effects of Dopamine Agonist for the Treatment of Restless Legs Syndrome

Regulation of inflammatory pathways by cannabigerol in the collagen induced arthritis model in rats

Advances in Clinical Application on Nursing Intervention for Ribavirin-Associated Adverse Events

Atorvastatin as an Immunomodulatory Adjunct in Ulcerative Colitis, Beyond Lipid Lowering to Inflammation Control: A Randomized Controlled Pilot Study

Development of a Venous Thromboembolism Risk Prediction Model for Patients with Primary Membranous Nephropathy Based on Machine LearningDevelopment of a Personalized VTE Risk Prediction Model for Patients with Primary Membranous Nephropathy Based on Machine Learning

PLGA-based nanoparticles in colorectal cancer immunotherapy: current concepts and future perspectives

Cost-effectiveness of Edaravone Dexborneol Sublingual Tablet Versus Concentrated Solution for Injection for the Treatment of Acute Ischemic Stroke in China

Effect of Recombinant Human Erythropoietin on Postoperative Anemia in Children and Adolescents Undergoing Osteosarcoma and Potential Influencing Factors: A Single-center Retrospective Study

Bromodomain-containing 4 as a therapeutic target in inflammatory bowel diseases and colorectal cancer